3rd Quarter - Report — ALERE INC. for ALERE INC. (2012)

Firm

ALERE INC.

Client

ALERE INC.

Income

—

Expenses

$153,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Medicare quality measurement issues Medicare coverage of clinical diagnostic laboratory tests

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC)

Medical/Disease Research/Clinical Labs MED

Development of new and innovative in-vitro diagnostic tests.

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Health Issues HCR

FDA regulation of laboratory tests (S. 3185, Food and Drug Administration Innovation and Safety Act) FDA regulation of prescription drugs

Lobbyist	Covered position, as disclosed
SETH M RADUS	—

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC)

Bills named: S. 3185 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.